Anthogyr and the Straumann Group have agreed for the latter to increase its stake in the former from 30% to 100%.
President and CEO of Anthogyr, Eric Genève, said: “Straumann provides us with the global platform and resources we need to expand internationally. We are immensely proud of our union with the world’s leading implant company and are convinced that it will add value for our staff, customers and patients.”
“Anthogyr and the Straumann Group have agreed for the latter to increase its stake in the former from 30% to 100%. “
CEO of the Straumann Group, Marco Gadola, said: “Our companies are a good cultural fit and our partnership over the past three years has been very successful. Anthogyr provided us with timely footholds in the non-premium implant segments in China and Russia, where we have been able to generate strong growth with the brand. Our goal is to drive its international expansion together with Neodent, Medentika and our other brands, offering customers and their patients’ high-quality implant solutions with a broader range of price options than other companies can offer.”